ArticleCore evidence2012

Polifeprosan 20, 3.85% carmustine slow-release wafer in malignant glioma: evidence for role in era of standard adjuvant temozolomide.

Lawrence KleinbergPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.